In vivo dopaminergic and serotonergic dysfunction in DCTN1 gene mutation carriers

INTRODUCTION: We have used positron emission tomography (PET) to assess dopaminergic and serotonergic terminal density in three subjects carrying a mutation in the DCT1 gene, two clinically affected with Perry syndrome. METHODS: All subjects had brain imaging using 18F-6-fluoro-L-dopa (FDOPA, dopami...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Felicio, Andre C., Dinelle, Katherine, Agarwal, Pankaj A., McKenzie, Jessamyn, Heffernan, Nicole, Road, Jeremy D., Appel-Cresswell, Silke, Wszolek, Zbigniew K., Farrer, Matthew J., Schulzer, Michael, Sossi, Vesna, Stoessl, A. Jon
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4139463/
https://ncbi.nlm.nih.gov/pubmed/24797316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.25893
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares